Table 1 Baseline characteristics and follow-up details of the study cohort
Variables | Total cohort | Unadjusted | P value | Propensity matched | P value | ||
|---|---|---|---|---|---|---|---|
(n = 1251) | SLG | SG | SLG | SG | |||
n (%):161(13) | n (%):1090(87) | n (%): 152(12) | n (%): 1090(88) | ||||
Age (years) | 65.0 ± 12.2 | 64 [19] | 65 [19] | 0.294 | 64.5 [20] | 65 [19] | 0.413 |
Males- n (%) | 793 (63) | 96 (59.6) | 697 (63.9) | 0.294 | 91 (59.9) | 697 (63.9) | 0.325 |
BMI (Kg/m2) | 30.4 ± 6.8 | 30.2 [7.7] | 29.2 [8.0] | 0.117 | 30.4 [7.9] | 29.2 [7.9] | 0.081 |
Creatinine (mg/dl) | 1 [0.4] | 1[0.2] | 1[0.4] | 0.445 | 1 [0.2] | 1 [0.4] | 0.560 |
Diabetes-n (%) | 462 (37) | 65 (40.4) | 397 (36.4) | 0.337 | 60 (39.5) | 397 (36.4) | 0.474 |
HTN–n (%) | 946 (76) | 125 (77.6) | 821 (75.3) | 0.557 | 118 (77.6) | 821 (75.3) | 0.614 |
Tobacco- n (%) | 727 (58) | 111 (68.9) | 616 (56.5) | 0.003 | 102 (67.1) | 616 (56.5) | 0.014 |
Clopidogrel-n (%) | 877 (70) | 101 (62.7) | 776 (71.2) | 0.034 | 99 (65.1) | 776 (71.2) | 0.130 |
Heparin during procedure (units) | 9000 ± 3000 | 9000 ± 3000 | 8500 ± 3000 | 0.899 | 9000 ± 3000 | 9000 ± 3000 | 0.999 |
Time until TR band removal (minutues) | 200 ± 30 | 200 ± 40 | 200 ± 30 | 0.718 | 200 ± 30 | 200 ± 40 | 0.913 |
Fluoro time (min) | 5.4 [7] | 5.7 [7.2] | 5.3 [6.9] | 0.910 | 5.7 [7.2] | 5.3 [6.9] | 0.838 |
Patent Hemostasis | 978 (78) | 127 (78.8) | 851 (78.1) | 0.919 | 118 (77.6) | 851 (78.1) | 0.917 |
